Access to Pre-approval
and Unlicensed Medicines
If you are a qualified healthcare professional, you can access medicines available
through the pre-approval access programs (also known as early access, expanded access,
named patient, compassionate use and managed access)
Inceptua is running in partnership with pharmaceutical clients.
Pre-approval and unlicensed medicines access programs
Inceptua is supporting a large number of pharmaceutical and biotech companies, through its management of pre-approval access programs for their assets.
Currently Inceptua is managing programs covering a wide range of rare disease products, oncology products and infectious disease products, allowing physicians to access these medicines prior to their commercial approval.
The full list of ongoing pre-approval access programs being managed by Inceptua, along with their inclusion criteria, and geographic scope, can be viewed by registering with our IMAP portal
SUPPORTING YOU THROUGH THE ENTIRE PROCESS
- Ethical and compliant
- Directly partnered with the manufacturer
- Dedicated country expert Medicines Access Advisors
- Available by mail or phone
- Local language support
- Unparalleled regulatory guidance
- Easy-to-use online platform
- Global network of warehouses
- Rapid Response and delivery
We are here to help by providing
medicines
to ensure healthcare
professionals can provide critical
treatments to patients in need.
Access Portal
For US physicians please contact us at: access.us@inceptua.com
For physicians outside of the US please contact us at: access@inceptua.com